A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)
- Submitting institution
-
Cardiff University / Prifysgol Caerdydd
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 96650405
- Type
- D - Journal article
- DOI
-
10.3310/hta19830
- Title of journal
- Health Technology Assessment
- Article number
- -
- First page
- 1
- Volume
- 19
- Issue
- 83
- ISSN
- 1366-5278
- Open access status
- Out of scope for open access requirements
- Month of publication
- October
- Year of publication
- 2015
- URL
-
http://dx.doi.org/10.3310/hta19830
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
16
- Research group(s)
-
-
- Citation count
- 19
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
-
- Author contribution statement
- a: The author made a substantial contribution to the design of the study (encompassed qualitative study), to the organisation of the conduct of the study (focus groups), to carrying out the study; as well as to analysis and interpretation of study data; and
b: the author helped draft the output and critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
